Aviance Capital Partners LLC has increased its holdings in Zoetis Inc., indicating confidence in the company's future prospects....
ProShare Advisors LLC recently sold a significant number of shares in Zoetis Inc. (NYSE: ZTS), indicating a change in their investment strategy. Zoetis Inc....
On February 26, 2025, QuantWave, the automated forecasting platform, issued a short signal for Zoetis Inc. stock (ZTS) with a price of $164.44....
On March 27, 2025, QuantWave issued a short signal for ZOETIS INC. with the stock trading at 164.47 $. The forecast proved to be accurate as the price target of 143....
QuantWave, an automated forecasting platform, successfully reached its price target forecast for Zoetis Inc., generating a profit of 13.65%....
QuantWave, the automated forecasting platform, has once again proven its efficacy by accurately predicting the price movement of ZOETIS INC. stock....
QuantWave's forecast for ZOETIS INC. on February 28, 2025, signaled a short direction with the stock priced at 166.12 $. On April 8, 2025, the target price of 143....
QuantWave, an automated forecasting platform, successfully reached its price target forecast for ZOETIS INC. with a profit of 12.47%....
Zoetis Inc., a leading global animal health company, has caught the attention of investors as Xponance Inc. recently acquired 2814 shares of its stock....
Zoetis Inc. (NYSE:ZTS) has been gaining attention from investors as short interest in the company continues to rise....
Institutional investors have placed their bets on Public Service Enterprise Group Incorporated NYSE:PEG and were rewarded with a US$2.0 billion market cap gain last week....
Atmos Energy Corporation (NYSE: ATO) has been surpassing its counterparts in the utilities sector this year....
Abbott Laboratories, a leading global healthcare company, has reported its fourth-quarter and full-year 2024 results, exceeding market expectations....
Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....
Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....